News Briefing channel feed – Endpoints News

News Briefing channel feed

ArriVent inks ADC deal with Alphamab; Annexon's $125M offering

11 months ago

Corrected: Vilya raises $21M in Series A extension; Shionogi to open research center in San Diego

11 months ago

Novartis shares updated data for BTK inhibitor; Astellas resubmits BLA for cancer drug after CRL

11 months ago

Compugen, Nxera disclose milestone payments; Insmed aims for $650M offering

12 months ago

Insmed, Merus announce public offerings; AI startup raises $13M seed round

12 months ago

Agios sells rights to glioma drug to Royalty Pharma; Cargo’s $110M placement

12 months ago

Bicycle’s $555M placement; Tango Therapeutics scraps cancer program

Last year

Dyne's $305M offering; Nanobiotix delays Ph2 readout

Last year

Lyra to lay off 75% of its workers; Dupixent nears COPD decision

Last year

Foghorn’s $110M offering; Novovax investor withdraws proxy campaign

Last year

Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand Pharma

Last year

Adaptimmune’s debt financing deal; Tenaya to cut workers

Last year

Allogene's $110M offering; Apellis refinances

Last year

Deciphera had another bidder before Ono deal; Bristol Myers reports Ph3 fail in lung cancer

Last year

iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar

Last year

Royalty Pharma inks MS deal with ImmuNext; X4 sells its priority review voucher

Last year

Pharming ends deal with Orchard; Seres considers cost-cutting

Last year

Lykos’ MDMA therapy to go before FDA committee; GSK expands work with BioVersys

Last year

Gates, Novo Nordisk, Wellcome foundations put $300M in global health; BioNTech stops prostate cancer study

Last year

Royalty Pharma's milestone payment to Arrowhead; Abeona's $75M offering

Last year

Context Therapeutics' $100M placement; Blueprint raises guidance for rare disease drug

Last year

Editas, BMS extend T cell deal; KalVista seeks partner for preclinical HAE program

Last year

Daré's royalty deal; Qlaris Bio raises $24M

Last year

4P-Pharma raises €15M; Oncotelic Therapeutics sells rights to cancer assets

Last year

First page Previous page 7 8 91011 12 13 Next page Last page